Bridges C B, Fukuda K, Cox N J, Singleton J A
Division of Viral and Rickettsial Diseases, National Center for Infectious Diseases, USA.
MMWR Recomm Rep. 2001 Apr 20;50(RR-4):1-44.
This report updates the 2000 recommendations by the Advisory Committee on Immunization Practices (ACIP) on the use of influenza vaccine and antiviral agents (MMWR 2000;49[No. RR-3]:1-38). The 2001 recommendations include new or updated information regarding a) the cost-effectiveness of influenza vaccination; b) the influenza vaccine supply; c) neuraminidase-inhibitor antiviral drugs; d) the 2001-2002 trivalent vaccine virus strains, which are A/Moscow/10/99 (H3N2)-like, A/New Caledonia/20/99 (H1N1)-like, and B/Sichuan/379/99-like strains; and e) extension of the optimal time period for vaccination through November. A link to this report and other information regarding influenza can be accessed at the website for the Influenza Branch, Division of Viral and Rickettsial Diseases, National Center for Infectious Diseases, CDC at http://www.cdc.gov/ncidod/diseases/flu/fluvirus.htm.
本报告更新了免疫实践咨询委员会(ACIP)2000年关于流感疫苗和抗病毒药物使用的建议(《发病率与死亡率周报》2000年;49[第RR - 3号]:1 - 38)。2001年的建议包含以下新的或更新的信息:a)流感疫苗接种的成本效益;b)流感疫苗供应;c)神经氨酸酶抑制剂抗病毒药物;d)2001 - 2002年三价疫苗病毒株,即A/莫斯科/10/99(H3N2)类似株、A/新喀里多尼亚/20/99(H1N1)类似株和B/四川/379/99类似株;以及e)将最佳接种时间段延长至11月。可通过疾病控制与预防中心(CDC)国家传染病中心病毒与立克次体疾病司流感科的网站http://www.cdc.gov/ncidod/diseases/flu/fluvirus.htm获取本报告及其他有关流感信息的链接。